Laddar...
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein highly expressed by prostate cancer cells. PSMA-based radioligand therapy (RLT) emerged as a promising therapeutic option for prostate cancer in the early 2000s, and has been clinically validated with great enthusiasm during t...
Sparad:
| I publikationen: | Ann Nucl Med |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Singapore
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680309/ https://ncbi.nlm.nih.gov/pubmed/33175360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12149-020-01549-5 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|